These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 38892084)
1. Characterization of HIF-1α Knockout Primary Human Natural Killer Cells Including Populations in Allogeneic Glioblastoma. Nakazawa T; Morimoto T; Maeoka R; Yamada K; Matsuda R; Nakamura M; Nishimura F; Yamada S; Park YS; Tsujimura T; Nakagawa I Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892084 [TBL] [Abstract][Full Text] [Related]
2. CRISPR-Cas9-Mediated TIM3 Knockout in Human Natural Killer Cells Enhances Growth Inhibitory Effects on Human Glioma Cells. Morimoto T; Nakazawa T; Matsuda R; Nishimura F; Nakamura M; Yamada S; Nakagawa I; Park YS; Tsujimura T; Nakase H Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33800561 [TBL] [Abstract][Full Text] [Related]
3. CIS deletion by CRISPR/Cas9 enhances human primary natural killer cell functions against allogeneic glioblastoma. Nakazawa T; Morimoto T; Maeoka R; Matsuda R; Nakamura M; Nishimura F; Ouji N; Yamada S; Nakagawa I; Park YS; Ito T; Nakase H; Tsujimura T J Exp Clin Cancer Res; 2023 Aug; 42(1):205. PubMed ID: 37563692 [TBL] [Abstract][Full Text] [Related]
4. Single-Cell RNA Sequencing of Tumor-Infiltrating NK Cells Reveals that Inhibition of Transcription Factor HIF-1α Unleashes NK Cell Activity. Ni J; Wang X; Stojanovic A; Zhang Q; Wincher M; Bühler L; Arnold A; Correia MP; Winkler M; Koch PS; Sexl V; Höfer T; Cerwenka A Immunity; 2020 Jun; 52(6):1075-1087.e8. PubMed ID: 32445619 [TBL] [Abstract][Full Text] [Related]
5. Hypoxia-inducible factor-1 alpha expression is induced by IL-2 via the PI3K/mTOR pathway in hypoxic NK cells and supports effector functions in NKL cells and ex vivo expanded NK cells. Cluff E; Magdaleno CC; Fernandez E; House T; Swaminathan S; Varadaraj A; Rajasekaran N Cancer Immunol Immunother; 2022 Aug; 71(8):1989-2005. PubMed ID: 34999917 [TBL] [Abstract][Full Text] [Related]
6. Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma. Close HJ; Stead LF; Nsengimana J; Reilly KA; Droop A; Wurdak H; Mathew RK; Corns R; Newton-Bishop J; Melcher AA; Short SC; Cook GP; Wilson EB Clin Exp Immunol; 2020 Apr; 200(1):33-44. PubMed ID: 31784984 [TBL] [Abstract][Full Text] [Related]
7. Regulation of branched-chain amino acid metabolism by hypoxia-inducible factor in glioblastoma. Zhang B; Chen Y; Shi X; Zhou M; Bao L; Hatanpaa KJ; Patel T; DeBerardinis RJ; Wang Y; Luo W Cell Mol Life Sci; 2021 Jan; 78(1):195-206. PubMed ID: 32088728 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of Hypoxia Inducible Factor-1α in Primary Human Natural Killer Cells Using Small Interfering RNA Delivery with ExPERT ATx by MaxCyte. Velásquez SY; Baslar GE; Schulte J; Fuderer T; Lindner HA; Coulibaly A Curr Protoc; 2024 Feb; 4(2):e987. PubMed ID: 38327104 [TBL] [Abstract][Full Text] [Related]
9. FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma. Srivastava C; Irshad K; Dikshit B; Chattopadhyay P; Sarkar C; Gupta DK; Sinha S; Chosdol K Int J Cancer; 2018 Feb; 142(4):805-812. PubMed ID: 28994107 [TBL] [Abstract][Full Text] [Related]
10. Guo X; Mahlakõiv T; Ye Q; Somanchi S; He S; Rana H; DiFiglia A; Gleason J; van der Touw W; Hariri R; Zhang X J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33741730 [TBL] [Abstract][Full Text] [Related]
11. HIF1-positive and HIF1-negative glioblastoma cells compete in vitro but cooperate in tumor growth in vivo. Fiorenzo P; Mongiardi MP; Dimitri D; Cozzolino M; Ferri A; Montano N; Trevisi G; Maira G; Battistini L; Falchetti ML; Levi A; Pallini R Int J Oncol; 2010 Apr; 36(4):785-91. PubMed ID: 20198320 [TBL] [Abstract][Full Text] [Related]
12. Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR/Cas9 system suppressed the metastasis of pancreatic cancer. Li M; Xie H; Liu Y; Xia C; Cun X; Long Y; Chen X; Deng M; Guo R; Zhang Z; He Q J Control Release; 2019 Jun; 304():204-215. PubMed ID: 31100311 [TBL] [Abstract][Full Text] [Related]
13. A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells. Ahmed EM; Bandopadhyay G; Coyle B; Grabowska A Cell Oncol (Dordr); 2018 Jun; 41(3):319-328. PubMed ID: 29492900 [TBL] [Abstract][Full Text] [Related]
14. Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment. Nigim F; Cavanaugh J; Patel AP; Curry WT; Esaki S; Kasper EM; Chi AS; Louis DN; Martuza RL; Rabkin SD; Wakimoto H J Neuropathol Exp Neurol; 2015 Jul; 74(7):710-22. PubMed ID: 26083570 [TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor 1alpha and vascular endothelial growth factor in Glioblastoma Multiforme: a systematic review going beyond pathologic implications. Vageli DP; Doukas PG; Goupou K; Benos AD; Astara K; Zacharouli K; Sotiriou S; Ioannou M Oncol Res; 2024; 32(8):1239-1256. PubMed ID: 39055895 [TBL] [Abstract][Full Text] [Related]
16. A hypoxia-induced decrease of either MICA/B or Hsp70 on the membrane of tumor cells mediates immune escape from NK cells. Schilling D; Tetzlaff F; Konrad S; Li W; Multhoff G Cell Stress Chaperones; 2015 Jan; 20(1):139-47. PubMed ID: 25103413 [TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor-2α (HIF-2α), but not HIF-1α, is essential for hypoxic induction of class III β-tubulin expression in human glioblastoma cells. Bordji K; Grandval A; Cuhna-Alves L; Lechapt-Zalcman E; Bernaudin M FEBS J; 2014 Dec; 281(23):5220-36. PubMed ID: 25244496 [TBL] [Abstract][Full Text] [Related]
18. Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis. Ge X; Pan MH; Wang L; Li W; Jiang C; He J; Abouzid K; Liu LZ; Shi Z; Jiang BH Cell Death Dis; 2018 Nov; 9(11):1128. PubMed ID: 30425242 [TBL] [Abstract][Full Text] [Related]
19. HIF-1α/Wnt signaling-dependent control of gene transcription regulates neuronal differentiation of glioblastoma stem cells. Boso D; Rampazzo E; Zanon C; Bresolin S; Maule F; Porcù E; Cani A; Della Puppa A; Trentin L; Basso G; Persano L Theranostics; 2019; 9(17):4860-4877. PubMed ID: 31410187 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the effects of simulated hypoxia by CoCl Khakshour E; Bahreyni-Toossi MT; Anvari K; Shahram MA; Vaziri-Nezamdoust F; Azimian H Mutat Res; 2024; 828():111848. PubMed ID: 38154290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]